Dosage forms of compositions based on 1-(3-chloro-5-{[4-(4-chlorothiophen-2-yl). (4-cyclohexylpiperazin-1-yl)thiazol-2-yl] carbamoyl} pyridin-2yl)piperidine-carboxylic acid or salts thereof, for increasing blood platelet levels in humans
Disclosed in certain embodiments is an oral pharmaceutical dosage form comprising a pharmaceutically acceptable excipient and an effective amount of 1-(3-chloro-5-{[4-(4-chlorothiophen-2-yl)-5-(4-cyclohexylpiperazin-1-yl)thiazol-2-yl]carbamoyl}pyridin-2-yl) piperadine-4-carboxylic acid (Formula I) or a pharmaceutically acceptable salt thereof, to increase platelet levels in humans.
